Effective care of patients with type 2 diabetes and dyslipidemia: A nurse's perspective

被引:10
作者
Adiseshiah, M [1 ]
机构
[1] UCL, NHS Fdn Trust Hosp, Middlesex Hosp, London W1N 8AA, England
关键词
diabetes; dyslipidemia; nurse; patient care; statin;
D O I
10.1016/j.diabres.2005.03.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
By 2030, it is predicted that type 2 diabetes will affect 4.4% of the world's population, an estimated 366 million individuals. Diabetic dyslipidemia is a modifiable risk factor for cardiovascular disease, which is a major cause of premature mortality in type 2 diabetes. The management of diabetic dyslipidemia requires a multidisciplinary approach and the role of the nurse within the healthcare team is pivotal. Their broad remit positions nurses not only at the forefront of care, where they are well placed to recognize the clinical signs of the condition, but also as patient advisor, counselor, educator, monitor and motivator during the continuum of care. Poor concordance is a common problem for patients receiving multiple medications. Educating the patient about the importance of lifestyle change, and ensuring that lifestyle and pharmacological interventions are sustained are important components of effective care. Choosing therapies that enable patients to reach their treatment goals with a simple dosage regimen may also help to maximize patient concordance. Nurses must remain up to date with treatment options and management guidelines in order that they can communicate relevant information to patients, empowering them to make informed decisions about their health. Specific, measurable, achievable, relevant and time-specific (SMART) goals should be set for each patient. This form of individualized care, in which the patient becomes fully engaged with their treatment plan and personal goals appear attainable, may help to reduce the projected burden of type 2 diabetes and its complications on healthcare services in the future. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:S23 / S27
页数:5
相关论文
共 21 条
[1]  
ADISESHIAH MA, 2002, PRIMARY HLTH CARE, V12, P41
[2]  
*AUD COMM, 2000, TEST REV DIAB SERV E
[3]  
Betteridge DJ, 2004, DIABETOLOGIA, V47, pA73
[4]   The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men [J].
Cho, E ;
Rimm, EB ;
Stampfer, MJ ;
Willett, WC ;
Hu, FB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (05) :954-960
[5]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[6]   Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial [J].
Colhoun, HM ;
Betteridge, DJ ;
Durrington, PN ;
Hitman, GA ;
Neil, HAW ;
Livingstone, SJ ;
Thomason, MJ ;
Mackness, MI ;
Charlton-Menys, V ;
Fuller, JH .
LANCET, 2004, 364 (9435) :685-696
[7]   European guidelines on cardiovascular disease prevention in clinical practice -: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice [J].
De Backer, G ;
Ambrosioni, E ;
Borch-Johnsen, K ;
Brotons, C ;
Cifkova, R ;
Dallongeville, J ;
Ebrahim, S ;
Faergeman, O ;
Graham, I ;
Mancia, G ;
Cats, VM ;
Orth-Gomér, K ;
Perk, J ;
Pyörälä, K ;
Rodicio, JL ;
Sans, S ;
Sansoy, V ;
Sechtem, U ;
Silber, S ;
Thomsen, T ;
Wood, D .
EUROPEAN HEART JOURNAL, 2003, 24 (17) :1601-1610
[8]   Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study [J].
Donnan, PT ;
MacDonald, TM ;
Morris, AD .
DIABETIC MEDICINE, 2002, 19 (04) :279-284
[9]   American Heart Association call to action: Obesity as a major risk factor for coronary heart disease [J].
Eckel, RH ;
Krauss, RM .
CIRCULATION, 1998, 97 (21) :2099-2100
[10]  
EMSLIESMITH A, 2003, BR J DIABETES VASC D, V3, P54, DOI DOI 10.1177/14746514030030010901